Skip to main content
Premium Trial:

Request an Annual Quote

DermTech Raises $5.6 Million in Series B Round

NEW YORK (GenomeWeb News) – DermTech today announced that it has raised $5.6 million in a private round of financing to support future development and commercialization of its qPCR-based melanoma detection assay.

Jacobs Investment Company led the Series B financing with additional investments coming from other existing and new investors, which were not named.

DermTech will use the funds to complete commercial validation of the melanoma test — its first product — and to establish a CLIA-certified lab facility in order to provide clinical testing services, the company said.

The company's melanoma test measures the expression of multiple gene targets in RNA extracted from skin samples collected using custom adhesive strips that non-invasively lift cells from suspicious lesions.

DermTech began evaluating PCR platforms to support its commercial melanoma assay in 2011, but it has not yet disclosed what platform the test will run on.

According to DermTech, clinical studies have demonstrated that the test has the ability to distinguish melanoma from non-melanoma with greater than 95 percent sensitivity and more than 70 percent specificity.

"The acquisition of the Series B Financing will help the Company tremendously as we continue to validate our assay and drive toward commercialization on this important tool for clinicians," John Dobak, DermTech's president and CEO, said in a statement.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.